CIMAP1B
Ciliary microtubule associated protein 1B
Also known as: CMA1B_HUMAN, FAP123, ODF3B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A8MYP8
- Gene
- CIMAP1B
- Ensembl
- ENSG00000177989
- Chromosome
- 22
- Canonical length
- 253 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to be located in motile cilium. Predicted to be active in cytoskeleton. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
253 residues, UniProt reviewed canonical sequence.
>A8MYP8|CIMAP1B
1 MGSDAWVGLW RPHRPRGPIA AHYGGPGPKY KLPPNTGYAL HDPSRPRAPA FTFGARFPTQ
61 QTTCGPGPGH LVPARMTVRG TDGAPAYSIY GRPRRSAPFL TPGPGRYFPE RAGNATYPSA
121 PRHTIAPRNW GVQAEQQSPG PAAYTVPSLL GPRVIGKVSA PTCSIYGRRA AGSFFEDLSK
181 TPGPCAYQVV SPGVYKSRAP QFTILARTSL PQDNTRKPGP AAYNVDQHRK PRGWSFGIRH
241 SDYLAPLVTD ADNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CIMAP1B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 75 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 75 nTPM
- salivary gland: 47 nTPM
- fallopian tube: 47 nTPM
- lung: 36 nTPM
- appendix: 34 nTPM
- spleen: 27 nTPM
Single-cell type
- late spermatids: 1,271 nCPM
- fallopian tube ciliated cells: 1,050 nCPM
- epididymal efferent duct ciliated cells: 829 nCPM
- respiratory ciliated cells: 774 nCPM
- endometrial ciliated cells: 491 nCPM
- early spermatids: 182 nCPM
Immune cell
- classical monocyte: 94 nTPM
- intermediate monocyte: 82 nTPM
- neutrophil: 66 nTPM
- non-classical monocyte: 58 nTPM
- myeloid DC: 57 nTPM
- total PBMC: 29 nTPM
Brain region
- medulla oblongata: 77 nTPM
- midbrain: 69 nTPM
- choroid plexus: 42 nTPM
- spinal cord: 35 nTPM
- pons: 33 nTPM
- thalamus: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.11
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CIMAP1B as an antibody target. Whether an autoantibody or antibody against CIMAP1B could matter depends on whether native CIMAP1B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CIMAP1B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CIMAP1B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...